🔎 Trials Near Me

Home › Idiopathic Thrombocytopenic Purpura › California › Los Angeles

Idiopathic Thrombocytopenic Purpura clinical trials in Los Angeles, CA

7 studies for Idiopathic Thrombocytopenic Purpura are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia

RecruitingPhase 1/2
  • USC Norris Comprehensive Cancer Center, Los Angeles
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT06721013

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

RecruitingPhase 3
  • USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235

Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders

RecruitingPhase 2
  • Usc Norris Comprehensive Cancer Center, Los Angeles
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07104565

A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)

RecruitingPhase 3
  • University of Southern California, Los Angeles
Ages 18 to 70 · All sexes · Updated Sep 11, 2026 · NCT07059000

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

RecruitingPhase 3
  • USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06948318

Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment

RecruitingPhase 3
  • University of Southern California (USC), Los Angeles
Ages 18 and older · All sexes · Updated Jun 22, 2026 · NCT07007962

A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia

RecruitingPhase 3
  • University of Southern California Norris Comprehensive Cancer Center, Los Angeles
Ages 18 and older · All sexes · Updated May 1, 2026 · NCT06544499

Idiopathic Thrombocytopenic Purpura trials in other cities

Other studies in Los Angeles

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.